Home/ Stocks/ LTRN

Lantern Pharma Inc. Common Stock

LTRN XNAS

$1.41 +0.17 (+14.17%) ▲ 15-min delayed

Open

$1.38

High

$2.11

Low

$1.35

Volume

14.18M

Market Cap

$13.81M

About Lantern Pharma Inc. Common Stock

Lantern Pharma Inc is an AI company transforming the cost, pace, and timeline of oncology drug discovery and development. Its proprietary AI and machine learning (ML) platform, RADR, uses oncology-focused data points and advanced ML algorithms to solve billion-dollar, real-world problems in cancer drug development. The group's growing pipeline of precision therapies has been accelerated using AI and input from world-class scientific advisors and collaborators.

Sector: PHARMACEUTICAL PREPARATIONS Employees: 24 Website →

Key Financials

Period	Revenue	Net Income	EPS
Q3 2025	$0	$-4,177,423	$-0.39
Q1 2025	$0	$-4,536,783	$-0.42
FY 2024	$0	$-20,781,213	$-1.93
Q3 2024	$0	$-4,505,697	$-0.42

Earnings & Analyst Ratings

Next Earnings: Wed, May 13, 2026

Calendar →

TickerDaily Coverage

Why Is Lantern Pharma Inc. Common Stock (LTRN) Stock Up 57.5% Today?

Penny Stocks Marcus Rivera · 4h ago

Lantern Pharma Inc. (LTRN) stock exploded higher Tuesday, March 31, 2026, jumping 57.5% to $1.88 on...

View All Coverage →

Get LTRN Alerts

Stay ahead with breaking news, price alerts, and expert analysis on Lantern Pharma Inc. Common Stock.

Disclaimer: This page is for informational purposes only. Stock data is delayed by at least 15 minutes. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.